Skip to main content

ORIGINAL RESEARCH article

Front. Oncol., 18 September 2020
Sec. Cancer Metabolism

RETRACTED: Seven-Gene Signature Based on Glycolysis Is Closely Related to the Prognosis and Tumor Immune Infiltration of Patients With Gastric Cancer

Retracted
\nShanshan Yu&#x;Shanshan Yu1Chuan Hu&#x;Chuan Hu2Luya CaiLuya Cai3Xuedan DuXuedan Du1Fan LinFan Lin4Qiongjie YuQiongjie Yu1Lixiao LiuLixiao Liu3Cheng ZhangCheng Zhang4Xuan LiuXuan Liu3Wenfeng LiWenfeng Li1Yu Zhan
Yu Zhan5*
  • 1Department of Chemoradiation Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
  • 2Department of Orthopaedic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
  • 3Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
  • 4Department of Dermatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
  • 5Department of Ultrasound, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Citation: Yu S, Hu C, Cai L, Du X, Lin F, Yu Q, Liu L, Zhang C, Liu X, Li W and Zhan Y (2020) Seven-Gene Signature Based on Glycolysis Is Closely Related to the Prognosis and Tumor Immune Infiltration of Patients With Gastric Cancer. Front. Oncol. 10:1778. doi: 10.3389/fonc.2020.01778

Received: 29 May 2020; Accepted: 11 August 2020;
Published: 18 September 2020; Retracted: 17 September 2024.

Edited by:

Federica Sotgia, University of Salford, United Kingdom

Reviewed by:

Maria Letizia Taddei, University of Florence, Italy
Parames C. Sil, Bose Institute, India

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.